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Abstract Primary chronic headaches cause more dis-
ability and necessitate high utilisation of health care. Our
knowledge is based on selected populations, while
information from the general population is largely lack-
ing. An age and gender-stratified cross-sectional epide-
miological survey included 30,000 persons aged
30–44 years. Respondents with self-reported chronic
headache were interviewed by physicians. The Interna-
tional Classification of Headache Disorders was used. Of
all primary chronic headache sufferers, 80% had con-
sulted their general practitioner (GP), of these 19% had
also consulted a neurologist and 4% had been hospita-
lised. Co-occurrence of migraine increased the probabil-
ity of contact with a physician. A high Severity of
Dependence Scale score increased the probability for
contact with a physician. Complementary and alternative
medicine (CAM) was used by 62%, most often physio-
therapy, acupuncture and chiropractic. Contact with a
physician increased the probability of use of CAM.
Acute headache medications were taken by 87%, while
only 3% used prophylactic medication. GPs manage the
majority of those with primary chronic headache, 1/5
never consults a physician for their headache, while
approximately 1/5 is referred to a neurologist or hospi-
talised. Acute headache medication was frequently
overused, while prophylactic medication was rarely used.
Thus, avoidance of acute headache medication overuse
and increased use of prophylactic medication may
improve the management of primary chronic headaches
in the future.
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Introduction
Headache is a common complaint in the general popula-
tion. The personal burden, social impact and economic cost
for both the sufferer and society are significant [1]. The
International Classification of Headache Disorders (ICHD-
II) divides headaches into primary and secondary forms
[2]. The most common primary headaches are migraine and
tension-type headaches, while other primary headaches are
rare [3]. The primary headaches are usually paroxysmal,
but 3% of the general population has primary chronic
headache, i.e. more than 15 headache days per months [4].
Headache accounts for 4% of the general practitioners
(GPs) consultations, and 2–4% of these are referred to
specialists or hospitals [5, 6]. Headache is probably the
most common reason for referral to neurologists [5–7].
Approximately 20–30% of all new referrals to out-patients
neurological departments are due to headache [5, 6, 8, 9].
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Our aim was to investigate primary chronic headache in
the general population in order to evaluate utility of health
services and medication use, since this knowledge is gen-
erally lacking.
Methods
General design
This is a cross-sectional epidemiological survey. A short
postal questionnaire screened for chronic headache
(C15 days/last month and/or C180 days/last year). Parti-
cipants with self-reported chronic headache were invited to
a clinical interview, a physical and neurological examina-
tion conducted by neurological residents. The response rate
of the screening questionnaire was 71% and the parti-
cipation rate of the interview was 74%. Figure 1 shows a
flow chart of the study. The method has been described in
more detail elsewhere [4].
Setting
The study was conducted in 2005 at Akershus University
Hospital, Oslo, Norway. Provision of health care in Nor-
way is based on a decentralized model. The state is
responsible for policy design, overall capacity and quality
of health care and hospital services. Almost all general
practices are private enterprises and their services are
contract based. The GPs are reimbursed through a fixed
annual fee, and fees for the specific services from the
National Health Insurance and the patients. Each Norwe-
gian citizen has through legislation the right to be on a GPs
list, and it is possible to change GP twice a year. The GP is
the gate keeper for referral to specialists and hospitals
except in emergencies.
Participants
A random sample of 30,000 persons aged 30–44 years and
stratified for age and gender was drawn from the general
population of eastern Akershus County, Norway. The area
includes rural and urban municipalities in close proximity
to Oslo.
Headache classification
The headaches were classified according to explicit diag-
nostic criteria of the ICHD-II and its relevant revisions, i.e.
the latest update was used in relation to chronic migraine
and medication overuse headache [2, 10–12]. Primary
chronic headache was defined as headache at least 15 days
per months for at least 3 months, not secondary to a head
trauma, brain tumour, etc. Those with medication overuse
as defined by ICHD-II were included as primary chronic
headache [2].
Physician consultation
We defined four levels of contact due to headache, i.e. none
(no physician contact), primary (GP), secondary (neurolo-
gist) and tertiary (hospitalisation). A GP referral is a pre-
requisite for access to neurologists, while both GP and
neurologist can refer to the hospital.
Complementary and alternative contacts
The complementary and alternative medicine (CAM)
forms queried were acupuncture, chiropractic, homeopa-
thy, naprapath, physiotherapy, psychologist and psycho-
motor physiotherapy.
Medication use and dependency
We asked about current medication use, and excluded
medication used for other pain conditions. To assess
dependency like behaviour, we used the The Severity of
Dependence Scale (SDS), which includes five questions
designed to measure psychological dependence (Table 1)
[13]. The questions apply to the headache medication taken
within the last month. Each item is scored on a 4-point
scale (0–3), and the total maximum score is 15. The
method has been described in detail elsewhere [14].Fig. 1 Flow chart of the participation
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Statistics
Data from the interviews were directly entered using SPSS
Data Entry 4.0 (SPSS Inc., Chicago, IL, USA) and statis-
tical analyses were performed using SPSS 15.00 for Win-
dows. For descriptive data, proportions, means and
confidence intervals (CI) are given. Pearson v2 test was
used for testing significance of group differences for cat-
egorical data, Fisher’s exact test was used when appropri-
ate. Student’s t test was used for numerical data.
Significance levels were set at p \ 0.05 and 95% CI were
calculated. CI and probabilities are not given when n \ 5.
Ethical issues
The Regional Committee for Medical Research Ethics and
the Norwegian Social Science Data Services approved the
study. All participants gave informed consent.
Results
Participants and headache diagnoses
A total of 405 participants (22% men and 78% women) had
primary chronic headaches. Ninety-five percent (n = 384)
had chronic tension-type headache (CTTH), 4% (n = 15)
had chronic migraine (CM), and 2% had other primary
chronic headache, i.e. new daily persistent headache
(n = 4) and chronic cluster headache (n = 1). Forty-nine
percent (n = 199) had co-occurrence of migraine and 46%
(n = 185) had medication overuse. The diagnoses are not
mutually exclusive.
Physician consultation pattern
Table 2 shows the physician and CAM contact pattern.
Twenty percent (79/405) had never consulted their GP
because of headache, while 80% (326/405) had consulted
their GP. The GP referred 1/4 with primary chronic head-
ache to neurologist and 4% had been hospitalised.
Significantly more women than men had had contact with
their GP (83 vs. 73%, p = 0.044), while referral was not
influenced by gender.
Complementary and alternative medicine
CAM was used by 62% (253/405) (Table 2). Physiother-
apy, acupuncture and chiropractic were most frequently
used. The use of CAM was significantly higher among
those who had consulted a physician compared to those
who had not such contact (p \ 0.001). Of those who did
not consult a physician 30% had used CAM to treat their
headache. Significantly more women than men had used
CAM (67 vs. 48%, p = 0.002), physiotherapy being the
only subgroup with a significant difference (57% women
vs. men 36%, p = 0.001).
Co-occurrence of migraine
Table 3 shows that co-occurrence of migraine as compared
to no co-occurrence of migraine significantly increased the
physician contact (p \ 0.001), while referral to hospital
was not significantly different in the two groups.
The overall use of CAM was not influenced by
migraine, but significantly more with than without co-
occurrence of migraine had acupuncture and physiotherapy
(p \ 0.05).
Co-occurrence of medication overuse
Medication overuse neither influenced the consultation
pattern nor CAM. However, significantly more with than
without medication overuse had co-occurrence of migraine
(p = 0.001).
Use of medication
Acute medication was used by 87, and 9% used it on a
daily basis. A higher proportion of participants with than
without co-occurrence of migraine used acute medication
(93 vs. 81%, p \ 0.001). More women than men used acute
Table 1 The five questions of the Severity Dependence Scale (SDS) adapted for headache medication
1 Do you think your use of headache medication was out of control? (never/almost never = 0, sometimes = 1, often = 2, always/nearly
always = 3)
2 Did the prospect of missing a dose make you anxious or worried? (scoring as for question 1)
3 Did you worry about your use of your headache medication? (scoring as for question 1)
4 Did you wish you could stop? (scoring as for question 1)
5 How difficult would you find it to stop or go without your headache medication? (not difficult = 0, quite difficult = 1, very difficult = 2,
impossible = 3)
‘‘Your headache medication’’ was in the interview replaced with the name of the individually relevant headache medication. Each item is scored
on a 4-point scale (0–3), and the total maximum score is 15
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medication (89 vs. 79%, p = 0.009). Participants using
acute medication had significantly more physician contact
than participants not using acute medication (82 vs. 18%,
p = 0.035).
Simple analgesic such as paracetamol (acetaminophen)
and ibuprofen were most frequently overused 62% (n = 115),
followed by combination analgesics 28% (n = 51). Triptans,
ergotamines, opioids and combination of acute medications
were overused by 10% (n = 10). Co-occurrence of migraine
did not influence which drugs that were overused except that
triptans were only overused by those with co-occurrence of
migraine. Only 4% used prophylactic treatment, with signif-
icantly more use in participants with than without co-occur-
rence of migraine (6 vs. 2%, p = 0.03).
The SDS score was significantly higher in those with
than without physician contact [4.3 (95% CI 4.0–4.6) vs.
3.2 (95% CI 2.6–3.8)], as well as in those with than without
medication overuse for all levels of physician contact
(Fig. 2).
Discussion
Presentation of main findings
Our main finding is that the majority of primary chronic
headache sufferers (80%) consulted their GP due to their
headache, while only 20% consulted a neurologist. Co-
occurrence of migraine and a high SDS score increased the
physician consulting rate. The use of CAM was high (62%)
and higher if a physician had been consulted than not.
Prophylactic headache medication was rarely used.
Methodological considerations
The sample size was chosen to ensure adequate numbers of
participants with chronic headache for the accurate
descriptive statistics. The large sample and high response
rates should ensure representative data from the general
population.
Table 2 Contact and treatment pattern in relation to different primary chronic headache diagnoses
CTTH
without
medication
overuse
(N = 216)
% (n)
CTTH with
medication
overuse
(N = 169)
% (n)
Chronic migraine
without
medication
overuse (N = 3)
% (n)
Chronic
migraine with
medication
overuse
(N = 14)
% (n)
Other primary
chronic headache
without medication
overuse (N = 3)
% (n)
Other primary
chronic headache
with medication
overuse (N = 7)
% (n)
All primary
headaches
(N = 405)
% (n)
Contact level
None 22 (47) 17 (28) 0 (0) 14 (2) 33 (1) 14 (1) 20 (79)
Primary 78 (169) 83 (141) 100 (3) 86 (12) 67 (2) 86 (6) 80 (326)
Secondary 16 (34) 20 (33) 33 (1) 36 (5) 67 (2) 71 (5) 19 (76)
Tertiary 4 (9) 4 (7) 0 (0) 0 (0) 33 (1) 0 (0) 4 (17)
Complementary and alternative medicine
Acupuncture 30 (65) 34 (58) 0 (0) 57 (8)d 67 (2) 43 (3) 33 (133)
Chiropractic 29 (62) 28 (47) 0 (0) 29 (4) 33 (1) 14 (1) 28 (113)
Homeopathy 11 (23) 10 (17) 0 (0) 14 (2) 33 (1) 29 (2) 11 (44)
Naprapath 6 (13) 4 (6) 0 (0) 0 (0) 33 (1) 0 (0) 5 (20)
Physiotherapy 50 (109) 56 (94) 0 (0) 57 (8) 33 (1) 43 (3) 52 (211)
Psychologist 2 (4) 2 (3) 0 (0) 0 (0) 33 (1) 0 (0) 2 (8)
Psychomotor
physiotherapy
6 (14) 10 (17) 0 (0) 0 (0) 0 (0) 0 (0) 8 (31)
Any CAM 61 (132) 65 (110) 0 (0) 64 (9) 67 (2) 57 (4) 62 (253)
Medication use
Acute
medication
75 (163)b 100 (169)a,c 100 (3) 100 (14) 100 (3) 100 (7) 87 (352)
Prophylactic
medication
3 (7) 3 (5) 0 (0) 7 (1) 0 (0) 14 (1) 3 (14)
Individual diagnoses are not mutually exclusive
a p \ 0.001 for CTTH with medication overuse versus CTTH without medication overuse
b p \ 0.001 for CTTH without medication overuse versus all other primary headaches
c p \ 0.001 for CTTH with medication overuse versus all other primary headaches
d p \ 0.05 for chronic migraine with medication overuse versus all other primary headache
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The age range of patients of 30–44 years was chosen in
order to target the highest number of participants with
‘‘pure’’ primary chronic headache, as the prevalence is
lower in younger people, and older people have a higher
risk of co-morbidity with other disorders. Furthermore,
data from the Norwegian prescription registry indicate that
the drug prescription pattern is different in people below
and above 50 years of age [15].
Two neurological residents with experience in headache
diagnostics conducted all interviews. The different headache
diagnoses were equally frequently set by both physicians,
suggesting that inter-observer variation was low. The head-
ache diagnoses were equally frequent in participants inter-
viewed at the clinic and in those interviewed by telephone.
Our data on medication use and health care utilisation
are based on self-reports and therefore open to recall bias,
although there is no reason to suspect systematic bias.
Health registry data are, however, often incomplete and not
necessarily more precise. In addition, registry data do not
exist for a majority of treatment contacts outside traditional
conventional medicine.
Physician contact
Twenty percent of the subjects with primary chronic
headache had never consulted a physician due to headache.
Table 3 Contact and treatment pattern for participants with primary chronic headaches
All primary headaches without
co-occurrence of migraine
(N = 206) % (n)
All primary headaches with
co-occurrence of migraine
(N = 199) % (n)
All primary headaches
without medication overuse
(N = 220) % (n)
All primary headaches
with medication overuse
(N = 185) % (n)
Contact level
None 28 (57) 11 (22)a 22 (48) 17 (31)
Primary 72 (149) 89 (177)a 78 (172) 83 (154)
Secondary 15 (31) 23 (45)a 16 (36) 22 (40)
Tertiary 5 (10) 4 (7) 5 (10) 4 (7)
Complementary and alternative medicine
Acupuncture 28 (57) 38 (76)b 30 (67) 36 (66)
Chiropractic 26 (54) 30 (59) 29 (63) 27 (50)
Homeopathy 10 (20) 12 (24) 11 (24) 11 (20)
Naprapath 5 (10) 5 (10) 6 (14) 3 (86)
Physiotherapy 47 (97) 57 (114)b 50 (110) 55 (101)
Psychologist 2 (4) 2 (4) 2 (5) 2 (3)
Psychomotor
physiotherapy
7 (14) 9 (17) 6 (14) 9 (17)
Any CAM 58 (120) 67 (133) 61 (134) 64 (119)
Medication use
Acute
medication
81 (167) 93 (185)a 76 (167) 100 (185)c
Prophylactic
medication
1 (3) 6 (11)b 3 (7) 4 (7)
Co-occurrence of
migraine
0 (0) 100 (199) 42 (92) 58 (107)c
Individual contacts and treatments are not mutually exclusive
a,b p \ 0.001 and p \ 0.05, respectively, for all primary chronic headaches with versus without migraine
c p \ 0.01 for all primary chronic headaches with versus without medication overuse
Fig. 2 Severity Dependence Scale (SDS) scores in participants with
primary chronic headache with (black) or without (dashed) medica-
tion overuse versus contact level
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The reason for this is unknown, but a possible reason may
be due to the low status of headache. For some people, the
chronic headache may represent just a minor problem in a
co-morbidity of other pain condition [5, 16]. It may also be
that some of those not consulting a physician prefer CAM
as a treatment option or they might manage their headache
adequately by themselves and do not feel a need for further
help. In a study conducted in a primary care population,
28% of those with chronic headache reported that they did
not need a consultation for their headache [17]. Thus, this
figure corresponds well with our figure. Eighty percent
consulted their GP for their primary chronic headache, and
1/4 was referred to a neurologist. The referral rate to
neurologists is quite low considering that the management
of chronic headaches is a real challenge that is often not
successful in primary care. Other population-based studies
on chronic headache found that 40–60% consulted their GP
and 13–28% was referred to a neurologist during the pre-
vious 6–12 months [18–20].
In our study, 4% had been admitted to hospital in-patient
treatment due to their headache. This is similar to a
European general population study [18], but low compared
to a US study [20]. The latter might be accounted for by
medication overuse headache primarily being caused by
analgesics and triptans in Europe, while barbiturates and
opioids are major challenges which often require hospi-
talisation in medication overuse headache in USA.
Co-occurrence of migraine increased the consultation
rate. Similarly, migraine caused a higher consultation rate
than tension-type headache in the general Danish popula-
tion [21, 22]. However, a French and an American study
found the consultation rate was not influenced by co-
occurrence of migraine among those who had chronic
headache [18, 20].
Use of complementary and alternative medicine
Over 60% of those with primary chronic headache had, at
some point, used CAM because of their headache. Other
studies have found that 40–90% of chronic headache suf-
ferers from different clinical settings use CAM for their
headache [23–25]. This indicates that chronic headache
sufferers like other chronic pain sufferers are likely to use
CAM as treatment [26, 27].
One reason for the high use of CAM despite the wide
range of traditional medical treatments for headache, may
be failure to achieve optimal control with medication.The
use of CAM is high and increasing in Norway and
worldwide [28, 29] and approximately 1/3 person in the
Norwegian general population who use CAM use it
because of headache [30]. A survey conducted in the UK
among CAM providers confirmed that headache is one of
the conditions believed to benefit mostly from different
CAM subtypes [31].
Use of medication
Eighty-seven percent used any acute medication for their
primary chronic headache, which is similar to the 84%
found in France [18]. Forty-six percent of those with pri-
mary chronic headache overused medication, which is a
high proportion compared to the 25–35% found in three
other population studies [19, 32, 33]. Part of this might be
explained by the use of different diagnostic criteria, i.e.
ICHD II versus criteria suggested by Silberstein [34, 35].
The distribution of type of overused medication is com-
parable to other population-based studies where simple
analgesics are most frequently overused and paracetamol
the main overused drug [18, 20, 33]. Paracetamol (acet-
aminophen) and ibuprofen are available as over-the-coun-
ter (OTC) drugs and are the most commonly used simple
analgesics in Norway.
The prevalence of medication overuse may also be
difficult to compare across studies using different data
collection methods. The condition may, in some settings,
be underreported.
The proportion of medication overuses among chronic
headache sufferers in the general population are lower than
that seen in headache clinics, and the spectrum of overused
medication differs slightly [18, 32, 33, 36–38].
In US it has been found that 23% of chronic headache
used acute medication on a daily basis [20] in contrast to
only 9% in the Norwegian general population. Norwegian
results comparable to those from the US are only found in
neurology out-patient settings [39].
The rare use of prophylactic treatment is surprising
considering the diagnosis of primary chronic headache and
the frequent use of acute headache medication.
The SDS was significantly higher in those with than
without medication overuse for all levels of physician
contact (Fig. 2). Primary chronic headache participants in
contact with physicians had significantly higher SDS than
those without such contact. Thus, our results support the
hypothesis that persons with physician contact differ from
those without such contact, and that people with physician
contact are likely to be more severe headache sufferers
with more disability, dependency-like characteristics and
other headache-related problems.
To alleviate the world wide problem of medication
overuse headache, it is important to educate those with
medication overuse headache to reduce their medication
consumption. We have previously described that a short
advice can reduce the medication use considerable and this
also leads to the reduction of the headache frequency [40].
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Conclusion
Primary chronic headache is most often treated by health
professionals, though 1/5 never consulted a physician. Co-
occurrence of migraine increases physician consultations and
affects treatment level within the health care system. CAM is
also a frequently used treatment option. The chronic headache
spectrum seen by GPs and neurologists differs. The high
degree of self-management, the high proportion of medication
overuse and the frequent use of less well-documented treat-
ment forms is a major concern. Improved management by
health professionals, not least GPs, as well as increased use of
prophylactic treatment and detoxification of medication
overuse is likely to alleviate the burden for those with primary
chronic headache. However, those patients who do not seek
medical contact also deserve attention.
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